Sleeping Buddha warning
This article was originally published in The Tan Sheet
Executive Summary
Issued by FDA March 10 advises the public not to "purchase or consume" a product known as Sleeping Buddha because it contains the unlabeled prescription drug ingredient estazolam, a benzodiazepine sedative. FDA notes estazolam may cause fetal damage if taken by pregnant women. Sleeping Buddha is being promoted for insomnia and restlessness, FDA says. The product's distributor, Burnaby, British Columbia-based Treasure Box Products, has begun a voluntary recall. Following a complaint from another manufacturer, Health Canada first initiated the recall with an announcement in December. The product was being distributed primarily by mail to customers in Canada, as well as in the metropolitan Seattle area...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning